Hoxton Financial’s Pfizer PFE Stock Holding History

Hoxton Financial’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	$348K	Buy	12,386 +6,885	+125%	+$197K	0.18%	49
2015 Q4	$168K	Sell	5,501 -4,621	-46%	-$145K	0.08%	75
2015 Q3	$302K	Hold	10,122	–	–	0.14%	57
2015 Q2	$322K	Hold	10,122	–	–	0.13%	58
2015 Q1	$334K	Sell	10,122 -21	-0.2%	-$668	0.14%	47
2014 Q4	$300K	Buy	10,143 +1,054	+12%	+$30.2K	0.13%	54
2014 Q3	$255K	Buy	9,089 +89	+1%	+$2.5K	0.11%	58
2014 Q2	$253K	Hold	9,000	–	–	0.11%	62
2014 Q1	$274K	Sell	9,000 -2,815	-24%	-$83.9K	0.12%	61
2013 Q4	$343K	Buy	+11,815	New	+$344K	0.15%	40
2013 Q3	–	Sell	-13,345	Closed	-$355K	–	508
2013 Q2	$355K	Buy	+13,345	New	+$369K	0.2%	30

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Hoxton Financial's PFE Position: Q1 2016 in Review

Hoxton Financial increased its Pfizer (PFE) stake by 125% in Q1 2016, buying an estimated $197K and bringing the position to 12,386 shares worth $348K. The position accounts for 0.18% of the portfolio, ranked #49.

Hoxton Financial first reported a position in PFE in Q2 2013 and has held it in 11 quarters since. The position peaked at $355K in Q2 2013. 1,968 funds tracked by Wall St. Rank hold PFE as of Q1 2016.

Hoxton Financial held 12,386 shares of Pfizer worth $348K as of Q1 2016.
Hoxton Financial bought 6,885 Pfizer shares in Q1 2016, an estimated $197K.
Pfizer made up 0.18% of Hoxton Financial's portfolio in Q1 2016, its #49 holding.
Hoxton Financial first reported a position in Pfizer in Q2 2013 and has held it in 11 quarters since.
Hoxton Financial's Pfizer position peaked at $355K in Q2 2013.
1,968 funds tracked by Wall St. Rank held Pfizer as of Q1 2016.

Based on Hoxton Financial's 13F filing for Q1 2016, filed 29 Apr 2016.